We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+4.95%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$33.6B
AUM Growth
+$255M
Cap. Flow
-$824M
Cap. Flow %
-2.45%
Top 10 Hldgs %
29.14%
Holding
1,152
New
97
Increased
418
Reduced
387
Closed
96

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$94.4M
2
ELV icon
Elevance Health
ELV
+$74.7M
3
PAYO icon
Payoneer
PAYO
+$71.5M
4
ABT icon
Abbott
ABT
+$64.2M
5
GE icon
GE Aerospace
GE
+$63.5M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$101M
2
AAPL icon
Apple
AAPL
+$98.8M
3
AMGN icon
Amgen
AMGN
+$85.8M
4
TXN icon
Texas Instruments
TXN
+$80.9M
5
BIIB icon
Biogen
BIIB
+$73M

Sector Composition

Rank Sector Weight
1 Technology 37.8%
2 Healthcare 15.65%
3 Consumer Discretionary 11.06%
4 Financials 8.19%
5 Industrials 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STNE icon
701
StoneCo
STNE
$2.23B
$2.2M 0.01%
183,131
-282,768
-61% -$4.17M
VSXY
702
Victoria's Secret
VSXY
$5.79B
$2.18M 0.01%
+123,274
New +$2.35M
IMNM icon
703
Immunome
IMNM
$2.72B
$2.17M 0.01%
+179,688
New +$2.81M
BJ icon
704
BJs Wholesale Club
BJ
$12B
$2.11M 0.01%
+24,044
New +$1.95M
CINF icon
705
Cincinnati Financial
CINF
$26.3B
$2.1M 0.01%
17,815
+15,438
+649% +$1.81M
CSGS
706
DELISTED
CSG Systems International
CSGS
$2.1M 0.01%
50,925
CGAU
707
Centerra Gold
CGAU
$4.32B
$2.1M 0.01%
+311,873
New +$2.05M
LH icon
708
Labcorp
LH
$26.3B
$2.09M 0.01%
10,283
+8,633
+523% +$1.76M
FFIV icon
709
F5
FFIV
$24.4B
$2.09M 0.01%
12,133
+10,832
+833% +$1.89M
XEL icon
710
Xcel Energy
XEL
$45.3B
$2.09M 0.01%
39,060
+2,755
+8% +$150K
CSL icon
711
Carlisle Companies
CSL
$12.9B
$2.08M 0.01%
5,140
+672
+15% +$271K
RMBS icon
712
Rambus
RMBS
$9.01B
$2.05M 0.01%
34,957
-117,524
-77% -$6.72M
SSNC icon
713
SS&C Technologies
SSNC
$19.1B
$2.05M 0.01%
32,722
-42,710
-57% -$2.65M
CNQ icon
714
Canadian Natural Resources
CNQ
$106B
$2.05M 0.01%
57,522
+3,994
+7% +$150K
CABA icon
715
Cabaletta Bio
CABA
$441M
$2.03M 0.01%
270,778
+92,616
+52% +$1.14M
NABL icon
716
N-able
NABL
$761M
$2.02M 0.01%
132,932
DLX icon
717
Deluxe
DLX
$1.08B
$2.02M 0.01%
90,100
SCSC icon
718
Scansource
SCSC
$1.17B
$2.02M 0.01%
45,600
-375
-0.8% -$16.8K
LOPE icon
719
Grand Canyon Education
LOPE
$4B
$2.02M 0.01%
14,435
-6,206
-30% -$855K
GFS icon
720
GlobalFoundries
GFS
$23.5B
$2.01M 0.01%
39,815
+2,696
+7% +$135K
CPB icon
721
Campbell Soup
CPB
$6.37B
$2.01M 0.01%
44,508
-10,913
-20% -$486K
BMBL icon
722
Bumble
BMBL
$399M
$2.01M 0.01%
191,064
+179,757
+1,590% +$1.96M
MTX icon
723
Minerals Technologies
MTX
$2.11B
$2.01M 0.01%
24,143
LNC icon
724
Lincoln National
LNC
$8.32B
$2.01M 0.01%
+64,553
New +$1.95M
OXY icon
725
Occidental Petroleum
OXY
$63.5B
$2M 0.01%
31,721
+349
+1% +$22.4K

Similar funds

Axa's Q2 2024 Portfolio in Review

As of Q2 2024, Axa held 1,152 positions worth $33.6B, up 0.76% from $33.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Axa's Q2 2024 filing shows 97 new, 418 increased, 387 reduced and 96 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 721,967 shares worth $27.8M. The largest sale was UnitedHealth, an estimated $101M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 721,967 shares worth $27.8M.
  • Axa added most to Advanced Micro Devices in Q2 2024, an estimated $94.4M increase.
  • Axa's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $101M.
  • Axa fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $46.4M.
  • Axa's ten largest holdings make up 29% of its $33.6B portfolio in Q2 2024.
  • Axa opened 97 new positions and closed 96 in Q2 2024.
  • Axa's portfolio value rose 0.76% quarter-over-quarter to $33.6B.

Based on Axa's 13F filing for Q2 2024, filed 14 Aug 2024.